Your browser doesn't support javascript.
loading
Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data.
Marcks, Nick; Aimo, Alberto; Januzzi, James L; Vergaro, Giuseppe; Clerico, Aldo; Latini, Roberto; Meessen, Jennifer; Anand, Inder S; Cohn, Jay N; Gravning, Jørgen; Ueland, Thor; Bayes-Genis, Antoni; Lupón, Josep; de Boer, Rudolf A; Yoshihisa, Akiomi; Takeishi, Yasuchika; Egstrup, Michael; Gustafsson, Ida; Gaggin, Hanna K; Eggers, Kai M; Huber, Kurt; Tentzeris, Ioannis; Ripoli, Andrea; Passino, Claudio; Sanders-van Wijk, Sandra; Emdin, Michele; Brunner-La Rocca, Hans-Peter.
Afiliación
  • Marcks N; Department of Cardiology, Maastricht University Medical Centre, PO Box 5800, 6202AZ, Maastricht, The Netherlands.
  • Aimo A; Cardiology Division, University Hospital of Pisa, Pisa, Italy.
  • Januzzi JL; Massachusetts General Hospital and Baim Institute for Clinical Research, Boston, USA.
  • Vergaro G; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
  • Clerico A; Fondazione Toscana G. Monasterio, Pisa, Italy.
  • Latini R; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
  • Meessen J; Fondazione Toscana G. Monasterio, Pisa, Italy.
  • Anand IS; Department of Cardiovascular Medicine, Institute for Pharmacological Research Mario Negri IRCCS, Milan, Italy.
  • Cohn JN; Department of Cardiovascular Medicine, Institute for Pharmacological Research Mario Negri IRCCS, Milan, Italy.
  • Gravning J; Division of Cardiovascular Medicine, University of Minnesota, Minneapolis, USA.
  • Ueland T; Department of Cardiology, VA Medical Centre, Minneapolis, USA.
  • Bayes-Genis A; Division of Cardiovascular Medicine, University of Minnesota, Minneapolis, USA.
  • Lupón J; Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway.
  • de Boer RA; Centre for Heart Failure Research, University of Oslo, Oslo, Norway.
  • Yoshihisa A; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Takeishi Y; Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Egstrup M; K. G. Jebsen Thrombosis Research and Expertise Centre, University of Tromsø, Tromsø, Norway.
  • Gustafsson I; Hospital Universitari Germans Trias I Pujol, Badalona (Barcelona), Spain.
  • Gaggin HK; Hospital Universitari Germans Trias I Pujol, Badalona (Barcelona), Spain.
  • Eggers KM; University Medical Centre Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
  • Huber K; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
  • Tentzeris I; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
  • Ripoli A; Department of Cardiology, Bispebjerg University Hospital, København, Denmark.
  • Passino C; Department of Cardiology, Bispebjerg University Hospital, København, Denmark.
  • Sanders-van Wijk S; Massachusetts General Hospital and Baim Institute for Clinical Research, Boston, USA.
  • Emdin M; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.
  • Brunner-La Rocca HP; Faculty of Internal Medicine, Wilhelminenspital and Sigmund Freud University Medical School, Vienna, Austria.
Clin Res Cardiol ; 110(8): 1280-1291, 2021 Aug.
Article en En | MEDLINE | ID: mdl-33704552
BACKGROUND: Higher body mass index (BMI) is associated with better outcome compared with normal weight in patients with HF and other chronic diseases. It remains uncertain whether the apparent protective role of obesity relates to the absence of comorbidities. Therefore, we investigated the effect of BMI on outcome in younger patients without co-morbidities as compared to older patients with co-morbidities in a large heart failure (HF) population. METHODS: In an individual patient data analysis from pooled cohorts, 5,819 patients with chronic HF and data available on BMI, co-morbidities and outcome were analysed. Patients were divided into four groups based on BMI (i.e. ≤ 18.5 kg/m2, 18.5-25.0 kg/m2; 25.0-30.0 kg/m2; 30.0 kg/m2). Primary endpoints included all-cause mortality and HF hospitalization-free survival. RESULTS: Mean age was 65 ± 12 years, with a majority of males (78%), ischaemic HF and HF with reduced ejection fraction. Frequency of all-cause mortality or HF hospitalization was significantly worse in the lowest two BMI groups as compared to the other two groups; however, this effect was only seen in patients older than 75 years or having at least one relevant co-morbidity, and not in younger patients with HF only. After including medications and N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin concentrations into the model, the prognostic impact of BMI was largely absent even in the elderly group with co-morbidity. CONCLUSIONS: The present study suggests that obesity is a marker of less advanced disease, but does not have an independent protective effect in patients with chronic HF. Categories of BMI are only predictive of poor outcome in patients aged > 75 years or with at least one co-morbidity (bottom), but not in those aged < 75 years without co-morbidities (top). The prognostic effect largely disappears in multivariable analyses even for the former group. These findings question the protective effect of obesity in chronic heart failure (HF).
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_endocrine_disorders / 6_obesity / 6_other_circulatory_diseases Asunto principal: Insuficiencia Cardíaca / Obesidad Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Clin Res Cardiol Asunto de la revista: CARDIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_endocrine_disorders / 6_obesity / 6_other_circulatory_diseases Asunto principal: Insuficiencia Cardíaca / Obesidad Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Clin Res Cardiol Asunto de la revista: CARDIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos
...